DE60139625D1 - Gel oder Lösung enthaltend Dihydrotestosterone, deren Herstellungsverfahren und Verwendung - Google Patents
Gel oder Lösung enthaltend Dihydrotestosterone, deren Herstellungsverfahren und VerwendungInfo
- Publication number
- DE60139625D1 DE60139625D1 DE60139625T DE60139625T DE60139625D1 DE 60139625 D1 DE60139625 D1 DE 60139625D1 DE 60139625 T DE60139625 T DE 60139625T DE 60139625 T DE60139625 T DE 60139625T DE 60139625 D1 DE60139625 D1 DE 60139625D1
- Authority
- DE
- Germany
- Prior art keywords
- dht
- gel
- dihydrotestosterones
- preparation
- solution containing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- NVKAWKQGWWIWPM-ABEVXSGRSA-N 17-β-hydroxy-5-α-Androstan-3-one Chemical compound C1C(=O)CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CC[C@H]21 NVKAWKQGWWIWPM-ABEVXSGRSA-N 0.000 abstract 4
- 239000000203 mixture Substances 0.000 abstract 4
- 229960003473 androstanolone Drugs 0.000 abstract 3
- 229940124532 absorption promoter Drugs 0.000 abstract 2
- 239000003349 gelling agent Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000004962 physiological condition Effects 0.000 abstract 1
- 239000002904 solvent Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Prostheses (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP01403166A EP1317921B1 (de) | 2001-12-07 | 2001-12-07 | Gel oder Lösung enthaltend Dihydrotestosterone, deren Herstellungsverfahren und Verwendung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE60139625D1 true DE60139625D1 (de) | 2009-10-01 |
Family
ID=8183007
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE60139625T Expired - Lifetime DE60139625D1 (de) | 2001-12-07 | 2001-12-07 | Gel oder Lösung enthaltend Dihydrotestosterone, deren Herstellungsverfahren und Verwendung |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20030087885A1 (de) |
| EP (1) | EP1317921B1 (de) |
| AT (1) | ATE439829T1 (de) |
| AU (1) | AU2002364625A1 (de) |
| CA (1) | CA2469028C (de) |
| CY (1) | CY1110602T1 (de) |
| DE (1) | DE60139625D1 (de) |
| DK (1) | DK1317921T3 (de) |
| ES (1) | ES2330188T3 (de) |
| MX (1) | MXPA04005517A (de) |
| PT (1) | PT1317921E (de) |
| WO (1) | WO2003047548A1 (de) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6503894B1 (en) | 2000-08-30 | 2003-01-07 | Unimed Pharmaceuticals, Inc. | Pharmaceutical composition and method for treating hypogonadism |
| ES2283446T3 (es) * | 2000-12-22 | 2007-11-01 | DR. AUGUST WOLFF GMBH & CO. KG ARZNEIMITTEL | Composicion de gel basada en alcohol para el tratamiento del hipogonadismo por administracion transescrotal. |
| US20040072810A1 (en) * | 2001-11-07 | 2004-04-15 | Besins International Belgique | Pharmaceutical composition in the form of a gel or a solution based on dihydrotestosterone, process for preparing it and uses thereof |
| SI1572178T1 (sl) * | 2002-12-18 | 2006-10-31 | Besins Int Lab | Zdravljenje mastalgije s 4-hidroksi-tamoksifenom |
| EP1952809B1 (de) * | 2002-12-18 | 2017-08-02 | Besins Healthcare Luxembourg SARL | Formulierungen für die Reduzierung der Brustdichte mit 4-Hydroxi-Tamoxifen |
| EP1941871B1 (de) * | 2003-04-01 | 2014-01-08 | Besins Healthcare Luxembourg SARL | Formulierungen für die Prävention und Behandlung von Brustkrebs mit 4-Hydroxy-Tamoxifen |
| DK1631275T3 (da) * | 2003-06-09 | 2008-08-18 | Ascend Therapeutics Inc | Behandling og forebyggelse af excessiv ardannelse med 4-hydroxy-tamoxifen |
| US20050042182A1 (en) * | 2003-08-13 | 2005-02-24 | Moshe Arkin | Topical compositions of urea |
| US20050037040A1 (en) * | 2003-08-13 | 2005-02-17 | Moshe Arkin | Topical compositions of urea and ammonium lactate |
| US20050036953A1 (en) * | 2003-08-13 | 2005-02-17 | Moshe Arkin | Topical compositions of ammonium lactate |
| JP2007531694A (ja) * | 2003-07-11 | 2007-11-08 | マクロケム・コーポレーション | 局所適用医薬組成物 |
| US20050025833A1 (en) * | 2003-07-16 | 2005-02-03 | Chaim Aschkenasy | Pharmaceutical composition and method for transdermal drug delivery |
| US20050020552A1 (en) * | 2003-07-16 | 2005-01-27 | Chaim Aschkenasy | Pharmaceutical composition and method for transdermal drug delivery |
| US20050042268A1 (en) * | 2003-07-16 | 2005-02-24 | Chaim Aschkenasy | Pharmaceutical composition and method for transdermal drug delivery |
| EP1550440A1 (de) * | 2003-12-15 | 2005-07-06 | Laboratoires Besins International | Verwendung von 4-hydroxytamoxifen zur Herstellung eines Arzneimittels zur Behandlung von Gynäkomastie |
| US7968532B2 (en) * | 2003-12-15 | 2011-06-28 | Besins Healthcare Luxembourg | Treatment of gynecomastia with 4-hydroxy tamoxifen |
| PL1694319T3 (pl) * | 2003-12-15 | 2009-01-30 | Besins Healthcare Lu Sarl | Zastosowanie 4-hydroksytamoksyfenu do wytwarzania leku do leczenia ginekomastii |
| NZ549817A (en) * | 2004-03-22 | 2010-06-25 | Besins Int Lab | Treatment and prevention of benign breast disease with 4-hydroxy tamoxifen |
| EP1579856A1 (de) * | 2004-03-22 | 2005-09-28 | Laboratoires Besins International | 4-Hydroxytamoxifen zur Behandlung von benignen Brusterkrankungen |
| US7507769B2 (en) * | 2004-03-22 | 2009-03-24 | Laboratoires Besins International | Treatment and prevention of benign breast disease with 4-hydroxy tamoxifen |
| US20050208139A1 (en) * | 2004-03-22 | 2005-09-22 | Ascend Therapeutics, Inc. | Chemically stable compositions of 4-hydroxy tamoxifen |
| BRPI0515040B1 (pt) * | 2004-09-09 | 2021-10-13 | Besins Healthcare Luxembourg S.A.R.L | Géis de testosterona compreendendo propileno glicol como intensificador de penetração |
| EP1634583A1 (de) * | 2004-09-09 | 2006-03-15 | Laboratoires Besins International | Testosterongele enthaltend Propylenglykol als Resorptionsverstärker |
| JP2008536851A (ja) * | 2005-04-13 | 2008-09-11 | ユニメド ファーマスーティカルズ インク | 女性でテストステロンおよび関連ステロイドの濃度を増加させる方法 |
| FI3456329T3 (fi) | 2005-10-12 | 2025-02-27 | Besins Healthcare Lu Sarl | Parannettu testosteronigeeli ja käyttömenetelmä |
| AU2012200290B2 (en) * | 2005-10-19 | 2014-08-21 | Havah Therapeutics Pty Ltd | Reduction of side effects from aromatase inhibitors used for treating breast cancer |
| CA2626337C (en) | 2005-10-19 | 2015-12-29 | Chavah Pty Ltd | Reduction of side effects from aromatase inhibitors used for treating breast cancer |
| AU2012283681B2 (en) * | 2011-07-14 | 2016-06-23 | Sunnywipes Pty Ltd | Disinfecting formulations and uses thereof |
| CN113633644A (zh) | 2014-10-22 | 2021-11-12 | 哈瓦赫治疗有限公司 | 降低乳房摄影乳腺密度和/或乳腺癌风险的方法 |
| WO2017066827A1 (en) | 2015-10-22 | 2017-04-27 | Havah Therapeutics Pty Ltd | Methods of reducing mammographic breast density and/or breast cancer risk |
| CN109276539A (zh) * | 2018-11-08 | 2019-01-29 | 北京海霞润月更年期综合症医学研究院 | 一种睾酮凝胶及制备方法 |
| WO2020243777A1 (en) | 2019-06-03 | 2020-12-10 | Havah Therapeutics Pty Ltd | Pharmaceutical formulations and systems for delivery of an androgenic agent and an aromatase inhibitor and methods for use |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2519252A1 (fr) | 1982-01-07 | 1983-07-08 | Besins Jean | Medicament a base de dihydrotestosterone pour le traitement des deficits des secretions androgeniques testiculaires |
| US5152997A (en) * | 1990-12-11 | 1992-10-06 | Theratech, Inc. | Method and device for transdermally administering testosterone across nonscrotal skin at therapeutically effective levels |
| WO1997041865A1 (de) * | 1996-05-02 | 1997-11-13 | Azupharma Gmbh | Topische penile androgen-applikation zur behandlung der erektilen dysfunktion |
| US6562369B2 (en) * | 1999-12-16 | 2003-05-13 | Dermatrends, Inc. | Transdermal administration of androgenic drugs hydroxide-releasing agents as permeation enhancers |
-
2001
- 2001-12-07 PT PT01403166T patent/PT1317921E/pt unknown
- 2001-12-07 AT AT01403166T patent/ATE439829T1/de active
- 2001-12-07 EP EP01403166A patent/EP1317921B1/de not_active Expired - Lifetime
- 2001-12-07 DK DK01403166T patent/DK1317921T3/da active
- 2001-12-07 ES ES01403166T patent/ES2330188T3/es not_active Expired - Lifetime
- 2001-12-07 DE DE60139625T patent/DE60139625D1/de not_active Expired - Lifetime
-
2002
- 2002-03-13 US US10/099,725 patent/US20030087885A1/en not_active Abandoned
- 2002-12-04 CA CA2469028A patent/CA2469028C/fr not_active Expired - Lifetime
- 2002-12-04 WO PCT/FR2002/004176 patent/WO2003047548A1/fr not_active Ceased
- 2002-12-04 AU AU2002364625A patent/AU2002364625A1/en not_active Abandoned
- 2002-12-04 MX MXPA04005517A patent/MXPA04005517A/es active IP Right Grant
-
2009
- 2009-10-30 CY CY20091101134T patent/CY1110602T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2469028C (fr) | 2012-08-14 |
| AU2002364625A1 (en) | 2003-06-17 |
| PT1317921E (pt) | 2009-11-06 |
| EP1317921A1 (de) | 2003-06-11 |
| DK1317921T3 (da) | 2009-12-21 |
| EP1317921B1 (de) | 2009-08-19 |
| CY1110602T1 (el) | 2015-04-29 |
| ATE439829T1 (de) | 2009-09-15 |
| US20030087885A1 (en) | 2003-05-08 |
| ES2330188T3 (es) | 2009-12-07 |
| MXPA04005517A (es) | 2005-03-23 |
| WO2003047548A1 (fr) | 2003-06-12 |
| CA2469028A1 (fr) | 2003-06-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60139625D1 (de) | Gel oder Lösung enthaltend Dihydrotestosterone, deren Herstellungsverfahren und Verwendung | |
| ATE312103T1 (de) | Substituierte porphyrine und deren therapeutische verwendungen | |
| BR0110492A (pt) | Composto, composição farmacêutica que compreende esse composto, processo para a preparação de composição farmacêutica, utilização do composto e processo para a preparação do composto | |
| BR0109107A (pt) | Usos terapêuticos de mediadores ppar | |
| MY137535A (en) | New pyrrolidinium derivatives | |
| ES2167377T3 (es) | Derivados de piridina farmacologicamente activos y procedimientos para la preparacion de los mismos. | |
| ATE429210T1 (de) | Orale flüssige zusammensetzungen | |
| DK96588A (da) | Antitumirmiddel indeholdende makromolekylaere platinforbindelser | |
| BRPI0409133A (pt) | formulações farmacêuticas contendo metilnaltrexona | |
| ATE309206T1 (de) | Schwefel-substituierte sulfonylaminocarbonsäure n-arylamide, ihre herstellung, ihre anwendung und diese enthaltende pharmazeutische zusammensetzungen | |
| BR9909110A (pt) | Usos de esmilagenina e anzurogenina d, compoisção farmacêutica tendo propriedades intensificadoras da função cognitiva, processo para intensificar a função cognitiva, e, composição para uso do mesmo | |
| IS3156A7 (is) | Aðferð við framleiðslu á N1-súbstitúeruðum bensimidasólafleiðum til að nota við lækningar | |
| DK15589A (da) | Kemiske forbindelser | |
| IL146448A0 (en) | Dr4 antibodies and uses thereof | |
| ATE293595T1 (de) | Thyroidhormon-analoga und verfahren zu ihrer herstellung | |
| DE69924304D1 (de) | N-palmitoylethanolamid-enthaltende pharmazeutische zusammensetzungen und deren verwendung in der veterinärmedizin | |
| DE69831928D1 (de) | Von Willenbrand Faktor (vWF) enthaltende Zubereitung, verfahren zür Herstellung von vWF enthaltenden Zubereitungen und deren Verwendung | |
| IL105646A0 (en) | Sulfonylbenzyl-substituted benzo-and pyridopyridones,their preparation and pharmaceutical compositions containing them | |
| DE69533043D1 (de) | Acrylamid-derivate und verfahren zu deren herstellung | |
| BR0206852A (pt) | Conjugados de polìmero de neublastina e métodos para uso dos mesmos | |
| ES2059457T3 (es) | Utilizacion de bezafibrato para el tratamiento de la diabetes. | |
| ATE3552T1 (de) | Verfahren zur herstellung von phosphono-hydroxy- essigsaeure und salzen derselben sowie diese enthaltende autivirale mittel. | |
| DE3577443D1 (de) | Derivate von dihydroorotsaeure, deren verfahren zur herstellung und deren pharmazeutische zusammensetzungen. | |
| DE69403110D1 (de) | Zyklische Angiopeptin Derivate, deren Herstellung und pharmazeutische Zusammensetzungen | |
| ATE106732T1 (de) | Arzneimittelzubereitung, enthaltend stigmasta-4- en-3-on sowie deren verwendung. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8327 | Change in the person/name/address of the patent owner |
Owner name: BESINS MANUFACTURING BELGIUM, BRUESSEL, BE |
|
| 8364 | No opposition during term of opposition | ||
| R082 | Change of representative |
Ref document number: 1317921 Country of ref document: EP Representative=s name: BOCKERMANN, KSOLL, GRIEPENSTROH, 44791 BOCHUM, DE |